Jm. Lehmann et al., AN ANTIDIABETIC THIAZOLIDINEDIONE IS A HIGH-AFFINITY LIGAND FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA(PPAR-GAMMA), The Journal of biological chemistry, 270(22), 1995, pp. 12953-12956
Thiazolidinedione derivatives are antidiabetic agents that increase th
e insulin sensitivity of target tissues in animal models of non-insuli
n dependent diabetes mellitus. In vitro, thiazolidinediones promote ad
ipocyte differentiation of preadipocyte and mesenchymal stem cell line
s; however, the molecular basis for this adipogenic effect has remaine
d unclear. Here, we report that thiazolidinediones are potent and sele
ctive activators of peroxisome proliferator activated receptor gamma (
PPAR gamma), a member of the nuclear receptor superfamily recently sho
wn to function in adipogenesis. The most potent of these agents, BRL49
653, binds to PPAR gamma with a K-d of approximately 40 nM. Treatment
of pluripotent C3H10T1/2 stem cells with BRL49653 results in efficient
differentiation to adipocytes. These data are the first demonstration
of a high affinity PPAR ligand and provide strong evidence that PPAR
gamma is a molecular target for the adipogenic effects of thiazolidine
diones. Furthermore, these data raise the intriguing possibility that
PPAR gamma is a target for the therapeutic actions of this class of co
mpounds.